Tsakmaklis, Anastasia
Farowski, Fedja
Zenner, Rafael
Lesker, Till Robin
Strowig, Till
Schlößer, Hans
Lehmann, Jonas
von Bergwelt-Baildon, Michael
Mauch, Cornelia
Schlaak, Max
Knuever, Jana
Schweinsberg, Viola
Heinzerling, Lucie M.
Vehreschild, Maria J. G. T.
Funding for this research was provided by:
Deutsche Krebshilfe (70112696, 70112696, 70112696, 70112696, 70112696, 70112696, 70112696, 70112696, 70112696, 70112696, 70112696)
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 29 July 2023
Accepted: 20 October 2023
First Online: 28 November 2023
Declarations
:
: The study was approved by the Ethics Committee of the Medical Faculty of the University of Cologne (Cologne-ID #17–269) and was conducted according to the principles expressed in the Declaration of Helsinki. Written informed consent was obtained from all patients.
: Not applicable.
: MJGTV reports grants and personal fees from 3M, Arderypharm, Astellas Pharma, Basilea, Bio-Mérieux, Biontech, DaVolterra, Evonik, FarmakInternational Holding GmbH, Ferring, Gilead Sciences, Glycom, Heel, Immunic AG, MaaT Pharma, Merck/MSD, Organobalance, Pfizer, Roche, Seres Therapeutics, SocraTec R&D GmbH, Takeda Pharmaceutical, Tillots Pharma GmbH.MS has received consultant or speaker fees or travel grants from BMS, MSD, Roche, Kyowa Kirin, Novartis, Sanofi Genzyme, Pierre Fabre, Sun Pharma, Immunocore.All remaining authors have declared that they have no competing interests.